6626 search
Vertex Pharmaceuticals Incorporated
NASDAQ VRTX 470,64 US$ 15,67%
Logo

Vertex draws upside bet before earnings

Publié le 26 janvier 2016

Vertex Pharmaceuticals is drawing bullish option activity ahead of its earnings report tomorrow afternoon.

optionMONSTER's Heat Seeker monitoring system detected the purchase of 1,200 February 100 calls for $3.20 and the sale of 1,200 February 110 calls for $0.70 yesterday. Volume was far above the open interest in both strikes, showing that these are new positions.

This vertical spread cost a net $2.50 to open and is looking for VRTX to rally above $100 by expiration in mid-February. The sale of the higher-strike contracts reduces the cost of the long calls but limits potential gains, as the trader will be obligated to sell shares if they rise above $110
(See our Coaching section.)

VRTX fell 2.73 percent to $92.12 yesterday and is down 21 percent in the last month. The drug developer's next quarterly report is scheduled to come out after the close on Jan. 27.

Overall option volume in the name was 4 times greater than average yesterday. Calls outnumbered puts by a bullish 47-to-1 ratio.

More From optionMONSTER

Les autres articles de la compagnie
Despite Market and Sector Risks, Why Credit Suisse Now Loves
Here Are the 10 Worst S&P 500 Stocks So Far in 2016
Here Are the 10 Worst S&P 500 Stocks So Far in 2016
Why Is It So Tough In Biotech?
As biotech stocks knife under their ‘Hillary’ low, analysts
Articles en illimité et contenus premium Je m'abonne
Editoriaux
et Nouvelles
Actions
Minières
Or et
Argent
Marchés La Cote
search 6626
search